ANAVEX LIFE SCIENCES CORP. Accounts Payable and Accrued Liabilities, Current
ANAVEX LIFE SCIENCES CORP. (AVXL) had Accounts Payable and Accrued Liabilities, Current of $800.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-28
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $800.00K.
- 2019-06-30: Accounts Payable and Accrued Liabilities, Current $4.34M.
- 2019-03-31: Accounts Payable and Accrued Liabilities, Current $6.37M.
- 2018-12-31: Accounts Payable and Accrued Liabilities, Current $4.88M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-28 |
| 2019-06-30 | $4.34M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $6.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.88M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $3.88M 10-Q · filed 2019-08-07 |
| 2018-06-30 | $3.21M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $3.42M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.80M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $3.58M 10-K · filed 2019-01-25 |
| 2017-06-30 | $1.44M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $2.03M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.16M 10-Q · filed 2017-02-07 |
| 2016-09-30 | $3.12M 10-K · filed 2017-12-11 |
| 2016-06-30 | $2.06M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.34M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $2.42M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $2.50M 10-K · filed 2016-12-14 |
| 2015-06-30 | $1.26M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.44M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.32M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $1.25M 10-K · filed 2015-12-29 |
| 2014-06-30 | $1.70M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.69M 10-Q/A · filed 2014-05-30 |
| 2013-12-31 | $1.62M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $1.74M 10-K · filed 2014-12-29 |
| 2013-06-30 | $2.80M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.67M 10-Q · filed 2013-05-17 |
| 2012-12-31 | $2.81M 10-Q · filed 2013-02-14 |
| 2012-09-30 | $2.59M 10-K · filed 2013-12-30 |
| 2012-06-30 | $2.17M 10-Q · filed 2012-08-17 |
| 2012-03-31 | $1.92M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.40M 10-Q · filed 2012-02-14 |
| 2011-09-30 | $410.02K 10-K · filed 2012-12-31 |
| 2011-06-30 | $1.37M 10-Q · filed 2011-08-12 |
| 2010-09-30 | $797.76K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |